A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 6, 1998, Pages 591-594

  Look, Katherine Y ^a   Blessing, John A ^b   Nelson, Beth E ^c   Johnson, Gary A ^d   Fowler Jr , Wesley C ^e   Reid, Gary C ^f  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f RIVERSIDE METHODIST HOSPITAL   (United States)

Author keywords

Interferon alpha; Isotretinoin; Squamous carcinoma of cervix

Indexed keywords

ALPHA INTERFERON; CYTOTOXIC AGENT; ISOTRETINOIN;

ADULT; AGED; ANEMIA; ANGIOGENESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMATION; DISEASE COURSE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOMAGNESEMIA; LEUKOPENIA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TISSUE CULTURE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON-ALPHA; ISOTRETINOIN; KERATOLYTIC AGENTS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; UTERINE CERVICAL NEOPLASMS;

EID: 0031794824     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199812000-00012     Document Type: Article

References (15)

1. Omura GA, Blessing JA, Vaccarello L, et al. Randomized trial of cisplatin versus cisplatin + mitolactol (dibromodulcitol) versus cisplatin + ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997;15:165-71.
2. Jetter AM, Kim JS, Sacks PG, et al. Inhibition of growth and squamous cell differentiation markers in cultured head and neck squamous carcinoma cells by beta-all trans retinoic acid. Int J Cancer 1990;45:195-202.
3. Smith MA, Parkinson DR, Cheson BD, et al. Retinoids in cancer therapy. J Clin Oncol 1992;10:837-62.
4. Lotan R, Sacks PG, Lotan D, et al. Differential effects of retinoic acid on the in vitro growth and cell surface glycoconjugates of two human head and neck squamous cell carcinomas. Int J Cancer 1987;40:224-9.
5. Ponect M, Weerheim A, Havekes L, et al. Effects of retinoids on differentiation, lipid metabolism, epidermal growth factor and low-density lipoprotein binding in squamous carcinoma cells. Exp Cell Res 1987;171:426-35.
6. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. New Engl J Med 1990;323:795-801.
7. Lippman SM, Garewal HS, Meyskens FL. Retinoids as potential chemopreventative agents in squamous cell carcinoma of the head and neck. Prev Med 1989;18:740-8.
8. Lippman SM, Shimm DS, Meyskens FL. Nonsurgical treatments for skin cancer: retinoids and alpha-interferon. Journal of Dermatologic Surgery and Oncology 1988;14:862-9.
9. Lippman SM, Parkinson DR, Weber RS, et al. Isotretinoin plus alpha interferon: effective therapy of advanced squamous cell carcinoma (scc) of the skin [abstract]. Proceedings of the American Society of Clinical Oncology 1991;10:197.
10. Weiner SA, Surwit EA, Graham VE, et al. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficiency. Invest New Drugs 1986;4:241-4.
11. Lippman SM, Kavanagh JJ, Paredes-Espinoze M, et al. 13-cis-retinoic-acid plus interferon alpha-2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst 1993;85:499-500.
12. Blessing JA. Design, analysis and interpretation of chemotherapy trials in gynecologic cancer. In: Deppe G, ed. Chemotherapy of gynecologic cancer. 2nd ed. New York: Alan R, Liss Inc., Scientific and Medical Publications, 1990;63-97.
13. Murad AM, Oliveira M, Saldanha TM. Phase II trial of isotretinoin and interferon alpha-2a in the treatment of advanced recurrent cervical carcinoma. International Journal of Gynecologic Cancer 1994;4:414-8.
14. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al. 13-cis-retinoic acid (1cRA), interferon alfa-21 and radiotherapy for locally advanced cancer of the cervix [abstract]. Proceedings of the American Society of Clinical Oncology 1993;12:257.
15. Hallum AV, Alberts DS, Lippman SM, et al. Phase II study of 13-cis-retinoic acid plus interferon-α2a in heavily pretreated squamous carcinoma of the cervix. Gynecol Oncol 1995; 56:382-6.